4-Hydroxythiobenzamide CAS 25984-63-8 Purity > 99.0% (HPLC) Febuxostat Intermediate Factory
Ruifu Chemical Supply Febuxostat Related Intermediates:
Febuxostat CAS 144060-53-7
Tom ntej: Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Tom ntej: Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Tom ntej: Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Tom ntej: Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Tom ntej: Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Tshuaj npe | 4-Hydroxythiobenzamide |
Synonyms | p-Hydroxythiobenzamide;4-Hydroxy-thiobenzamide;p-Hydroxythio-benzamide;4-Hydroxybenzenecarbothioamide;4-Hydroxybenzothioamide |
CAS Nr | 25984-63-8 |
CAT Number | Qauv: RF-PI1855 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C7H7 NOS |
Molecular Luj | 153.20 Nws |
Melting Point | 181.0 ~ 185.0 ℃ |
Qhov ntom | 1.338 ± 0.06 g / cm3 |
Solubility (Soluble hauv) | Soluble hauv Methanol |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Pale Yellow Solid Powder |
Purity / Analysis Method | > 99.0% (HPLC) |
Kev txheeb xyuas | Los ntawm HPLC;Los ntawm HNMR |
Poob rau ziab | <0.50% |
Residue ntawm Ignition | <0.20% |
Ib leeg Impurity | <0.50% |
Tag nrho cov impurities | <1.00% |
Test Standard | Enterprise Standard |
Kev siv | Intermediate of Febuxostat (CAS: 144060-53-7) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
4-Hydroxythiobenzamide (CAS: 25984-63-8) tuaj yeem siv los ua ib qho nruab nrab ntawm Febuxostat (CAS: 144060-53-7).Febuxostat, ib qho kev xaiv xanthine oxidase inhibitor, tau tsim los rau kev tswj xyuas mob ntev ntawm hyperuricemia hauv cov neeg mob gout.Hyperuricemia txhais tau tias yog cov ntshav uric acid concentration ntau tshaj qhov txwv ntawm solubility.Nws predisposes cuam tshuam rau cov neeg mob gout, ib tug kab mob tshwm sim los ntawm kev tsim cov crystals ntawm monosodium urate los yog uric acid los ntawm supersaturated kua nyob rau hauv cov pob qij txha thiab lwm yam ntaub so ntswg.